Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Health GroupHKSE:08225 EV-to-FCF is 6.08 as of Aug. 26, 2026. The stock has 4 warning signs investors should review. Among 104 Medical Diagnostics & Research companies, China Health Group ranks better than 90.38% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, China Health Group's Enterprise Value is HK$50.26 Mil.
China Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$8.27 Mil. Therefore, China Health Group's EV-to-FCF for today is 6.08.
The historical rank and industry rank for China Health Group's EV-to-FCF or its related term are showing as below:
HKSE:08225'
s EV-to-FCF Range Over the Past 10 Years
Min: -3532.75 Med: -2.76 Max: 122.05
Current: 6.08
During the past 13 years, the highest EV-to-FCF of China Health Group was 122.05. The lowest was -3532.75. And the median was -2.76.
HKSE:08225's EV-to-FCF is ranked better than 90.38% of 104
companies
in the Medical Diagnostics & Research industry
Industry Median: 26.965
vs HKSE:08225: 6.08
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Health Group (HKSE:08225) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Health Group's PE Ratio (TTM) for today is calculated as:
China Health Group's share price for today is HK$0.081.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.016.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
China Health Group EV-to-FCF Related Terms
China Health Group EV-to-FCF Historical Data
* Premium members only.
The historical data trend for China Health Group's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08225 vs TMO, DHR, IDXX: EV-to-FCF Comparison
For the Diagnostics & Research subindustry, China Health Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Group EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, China Health Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where China Health Group's EV-to-FCF falls into.
China Health Group's current Enterprise Value is HK$50.26 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$8.27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Group (HKSE:08225) has a EV-to-FCF of 6.08 as of Aug. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China Health Group and its competitors. According to the industry distribution chart, China Health Group ranks #10 out of 104 companies in the Medical Diagnostics & Research industry, placing it in the top 9.6%.
Is China Health Group's EV-to-FCF too high?
China Health Group's current EV-to-FCF is 6.08. The Medical Diagnostics & Research industry median EV-to-FCF is 26.97. China Health Group's value of 6.08 is 77.5% below this industry median. Based on the distribution chart, China Health Group ranks #10 out of 104 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does China Health Group's EV-to-FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, China Health Group ranks #10 out of 104 companies for EV-to-FCF. This places China Health Group in the top 10% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 26.97. China Health Group's value of 6.08 is 77.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 26.97, based on 104 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Health Group's current EV-to-FCF of 6.08 is 77.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China Health Group and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 26.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Group's current EV-to-FCF is 6.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Group stock overvalued right now?
Based on GuruFocus' analysis, China Health Group (HKSE:08225) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.21, compared to a current price of HK$0.08 — trading 61.4% below its estimated fair value. The current EV-to-FCF is 6.08 and 77.5% below the Medical Diagnostics & Research industry median of 26.97. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For China Health Group (HKSE:08225), the current EV-to-FCF is 6.08 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China Health Group Inc is an investment holding company engaged in providing medical care facilities in the People's Republic of China. The company provides provision of post-launch market research, medical and medical market services (PM services), Provision of contracted pharmaceutical development services (PD services), Provision of contracted clinical research services (CR Services), drug technologies, and Other medical services. The majority of its revenue for the company comes from the provision of PM services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08225 has been successfully added to your 
